Providers must meet all coverage criteria to be reimbursed by Medicare. The questions and answers below address coverage and reimbursement requirements.
CMS issued a national coverage decision (NCD) on February 10, 2022, announcing the expansion of coverage for lung cancer screening with low dose computed tomography (LDCT) for certain Medicare beneficiaries. Learn more »
2022 MLN Matters Article MM12691 : National Coverage Determination (NCD) 210.14 Reconsideration – Screening for Lung Cancer with Low Dose Computed Tomography (LDCT).
This MLN Matters article is for physicians, hospitals, and other providers billing Medicare Administrative Contractors (MACs) for lung cancer screening services they provide to Medicare patients.